Landmark genetic discrimination ban takes effect, removing barriers to life-saving genetic testing
Australians can now have genetic testing without fear that the results could be used against them when applying for life insurance, following the implementation of landmark federal legislation banning genetic discrimination in life insurance.
The legislative ban took full legal effect on 8 October 2026, marking a significant milestone for public health and disease prevention and paving the way for government investment in preventive genomic screening for adults. Until recently, life insurers were legally able to use genetic test results to deny coverage, increase premiums or place conditions on cover. As a result, many people chose not to pursue genetic testing, or delayed testing, because of concerns about the potential implications for future life insurance. The new legislative ban removes that barrier, allowing people to make decisions about genetic testing based on their health needs rather than financial concerns. The change represented the culmination of almost a decade of advocacy by legal and genomic expert Associate Professor Jane Tiller from the School of Public Health and Preventive Medicine, who worked closely with the government on the reform.
The reform is also expected to strengthen the case for future investment in preventive genomic screening programs. Earlier this year, Associate Professor Tiller described the ban as a "game changer" that creates new opportunities to expand access to population-scale genomic screening and preventive healthcare initiatives, including programs such as DNA Screen. Co-led by Associate Professor Tiller and Professor Paul Lacaze, DNA Screen is working towards a future national screening program that could make preventive genomic testing more broadly accessible to all adult Australians through the public health system.
“When people can access genetic risk information without fear of insurance discrimination, they are more likely to engage with testing that can identify serious health risks before disease develops, or at a stage when it can be detected earlier and treated more effectively.” Associate Professor Tiller said.
“This creates an unprecedented opportunity to expand preventive genomic screening in Australia, identify more people at high genetic risk and provide earlier interventions that can ultimately save lives.”
To mark the legislative ban coming into effect, DNA Screen hosted a special event on 8 October that brought together researchers, policymakers, politicians, clinicians, patient groups, and community members who have been part of this journey, joined by special guest the Hon Dr Daniel Mulino MP, Assistant Treasurer, who led the bill through Parliament.
“We are now enabling people in the community to benefit from preventative genetic testing in such a way that they won’t be disadvantaged in their life insurance, so they’ll be much more likely to get those tests earlier and benefit from them.” Dr Daniel Mulino said.
By removing the fear of insurance discrimination, the legislation does more than protect consumers. It enables Australians to make healthcare decisions based on their health needs rather than financial concerns, supports greater participation in genomic testing, and lays important foundations for a more preventive, equitable and effective healthcare system.
Click here for more news from the School of Public Health and Preventive Medicine